ANGLE : Angle announces new results for dual analysis of CTCDNA and ctDNA using Illumina assay and sequencing platform

Angle plc, a world─leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, has announced new, successful results for it's dual circulating tumour DNA (ctDNA) and CTC─DNA workflow using, for the first time, an end─to─end Illumina solution for analysis.